Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Clinical trial NCT00131911 · COMPLETED

Trial details

NCT number: NCT00131911
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrinoma Glucagonoma Insulinoma Metastatic Gastrointestinal Carcinoid Tumor Neuroendocrine Tumor Pancreatic Polypeptide Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Islet Cell Carcinoma Somatostatinoma WDHA Syndrome

Start date: 2005-06-01
Primary completion: 2010-10-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.